October 14, 2025 - Comments Off on Omega Ophthalmics LLC Announces Appointment of John W. Sheets, Jr., Ph.D., as Chief Operating Officer

Omega Ophthalmics LLC Announces Appointment of John W. Sheets, Jr., Ph.D., as Chief Operating Officer

Omega Ophthalmics LLC is thrilled to announce the appointment of John W. Sheets, Jr., Ph.D., as its new Chief Operating Officer. This key hire comes at an exciting time as the company advances its innovative ophthalmic technologies through the FDA approval process.

John brings a wealth of expertise and leadership to Omega Ophthalmics, with a distinguished career spanning senior roles in top-tier companies and government agencies within the ophthalmology field. His experience includes serving as Senior Vice President of Corporate Research at Boston Scientific, Head of Global Research and CTO at Bausch + Lomb, Global President and CEO of HOYA Surgical, CTO of Johnson & Johnson’s ETHICON, Director of the FDA’s Office of Device Evaluation, and Vice President of Surgical Research & Development at Alcon.

With his proven track record of driving innovation and navigating regulatory landscapes, John is ideally positioned to lead Omega Ophthalmics’ operations and help bring groundbreaking eye care solutions to market. The company looks forward to the dynamic growth and success his leadership will inspire.

Welcome to the team, John — together we are shaping the future of ophthalmic care!

Published by: Omega Ophthalmics in Company News

April 12, 2022 - Comments Off on Omega Ophthalmics CMO, Gary Wortz, MD Named on The Ophthalmologist’s 2022 Power List

Omega Ophthalmics CMO, Gary Wortz, MD Named on The Ophthalmologist’s 2022 Power List

New York, US, April 07, 2022 – After thousands of votes were received and the final list of nominees was scrutinized by an eminent panel of judges, Gary Wortz, MD has been selected to feature on the prestigious Power List from The Ophthalmologist, a leading publication in the field. For 2022, the list highlights the Top 100 most influential people in the world of ophthalmology, including the giants of clinical practice and vision research as well as up and coming talent, too.

Editors of The Ophthalmologist launched The Power List in 2014 to acknowledge and recognize those making waves in the field of ophthalmology – and beyond. Thousands of nominations were received from loyal readers of the publication, with the finalists chosen from a list of more than 450 names by an international panel of 20 judges. These annual awards have proven to be one of the most anticipated issues among readers year on year.

Aleksandra Jones, Editor of The Ophthalmologist, says, “Putting the annual Power List together is the highlight of my year! It is wonderful to see how much this honor means to the people selected for the list, and it’s a great opportunity to celebrate ophthalmology – one of the most forward-thinking fields of clinical practice and research.”

See The Ophthalmologist’s Power List 2022 here.

About The Ophthalmologist
The Ophthalmologist is a leading publication for professionals in all areas of ophthalmic clinical practice. Through its resources – website, newsletters, webinars, social channels, monthly print magazine and video – The Ophthalmologist gives its vast audience of readers a truly global and multimedia platform from which to learn, communicate, network and further the field of ophthalmology.

Published by: Omega Ophthalmics in Company News

September 13, 2016 - Comments Off on Omega Ophthalmics Receives Issuance of 2nd Continuation Alpha Patent from USPTO

Omega Ophthalmics Receives Issuance of 2nd Continuation Alpha Patent from USPTO

Lexington, KY – September 13, 2016

Omega Ophthalmics is pleased to announce that a 2nd continuation for its Alpha Family of patents has been issued by the United States Patent and Trademark Office.

This continuation is for invention number 9,439,754, a patent for a “prosthetic capsular bag and method of inserting the same."

Read more

Published by: Omega Ophthalmics in Company News, Intellectual Property, Press Releases

August 16, 2016 - Comments Off on Omega Ophthalmics Receives Issuance of 1st Continuation Bravo Patent from USPTO

Omega Ophthalmics Receives Issuance of 1st Continuation Bravo Patent from USPTO

Lexington, KY – August 16, 2016

Omega Ophthalmics is pleased to announce that a continuation for Prosthetic Capsular Devices, Systems, and Methods has been issued by the United States Patent & Trademark Office (USPTO).

The patent for invention number 9,414,907 is for a “Prosthetic Capsular Devices, Systems, and Methods,” and contains protections surrounding "wearable technology that provides biometric data, such as blood glucose levels, body temperature, electrolyte balance, heart rate...and the like that can assist in technology-assisted health care functions."

Read more

Published by: Omega Ophthalmics in Company News, Intellectual Property, Press Releases

June 7, 2016 - Comments Off on Omega Ophthalmics Issued Patent for Prosthetic Capsular Devices, Systems, and Methods by USPTO

Omega Ophthalmics Issued Patent for Prosthetic Capsular Devices, Systems, and Methods by USPTO

Lexington, KY – June 7, 2015

Omega Ophthalmics is pleased to announce that a patent for Prosthetic Capsular Devices, Systems, and Methods has been issued by the United States Patent & Trademark Office (USPTO).

The patent for invention number 9,358,103 is for a “Prosthetic Capsular Devices, Systems, and Methods,” and contains protections surrounding methods for inserting high-technology devices inside the eye.

Read more

Published by: Omega Ophthalmics in Company News, Intellectual Property, Press Releases